Liver stiffness based model for portal hypertension and hepatocellular cancer risk in HBV responsive to antivirals.
CONCLUSIONS: LSPS is useful to identify patients with regression of PH and EVs, avoiding endoscopy. LSPS ≤0.62 at baseline or due to antiviral therapy is associated with a lower risk of HCC. Early antiviral treatment is recommended in order to maintain or to induce LSPS ≤0.62.
PMID: 30356037 [PubMed - as supplied by publisher]
Source: Minerva Gastroenterologica e Dietologica - Category: Gastroenterology Tags: Minerva Gastroenterol Dietol Source Type: research
More News: Antiviral Therapy | Cancer | Cancer & Oncology | Carcinoma | Cirrhosis | Endoscopy | Esophagus Cancer | Gastroenterology | Hepatitis | Hepatitis B | Hepatocellular Carcinoma | Hypertension | Liver | Liver Cancer | Lower Endoscopy | Nutrition | Study | Urology & Nephrology